Vanadium mediated apoptosis and cell cycle arrest in MCF7 cell line

Fenech, 2001, Vitamins/minerals and genomic stability in humans, Mutat. Res., 475, 1, 10.1016/S0027-5107(01)00069-0 Elberg, 1998, Mechanism of action of vanadium in mediating the biological effects of insulin, 277 Thompson, 1984, Vanadyl (IV) sulphate inhibit chemically induced mammary carcinogenesis, Carcinogenesis, 5, 849, 10.1093/carcin/5.6.849 Bishayee, 1995, Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethylnitrosamine and promoted by phenobarbital, Br. J. Cancer, 71, 1214, 10.1038/bjc.1995.236 Bishayee, 1997, Vanadium-mediated suppression of diethlynitrosamine-induced chromosomal aberrations in rat hepatocytes and its correlation with induction of hepatic glutathione and glutathione S-transferase, Int. J. Oncol., 102, 413 Bishayee, 2000, Vanadium chemoprevention of 7,12-dimethylbenz(α)anthracene-induced rat mammary carcinogenesis: probable involvement of representative hepatic phase I and phase II xenometabolising enzymes, Breast Cancer Res. Treat., 63, 133, 10.1023/A:1006476003685 Steller, 1995, Mechanisms and genes of cellular suicide, Science, 267, 1445, 10.1126/science.7878463 Clarke, 1990, Development cell death: morphological diversity and multiple mechanisms, Anat. Embryol., 181, 195, 10.1007/BF00174615 Carson, 1993, Apoptosis and disease, Lancet, 341, 1251, 10.1016/0140-6736(93)91154-E Gougeon, 1993, Apoptosis in AIDS, Science, 260, 1269, 10.1126/science.8098552 Shibata, 2004, Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism, Carcinigenesis, 25, 1887, 10.1093/carcin/bgh201 Levenson, 1997, MCF-7: the first hormone-responsive breast cancer cell line, Cancer Res., 57, 3071 Soule, 1973, A human cell line from a pleural effusion derived from a breast carcinoma, J. Natl. Cancer Inst., 51, 1409, 10.1093/jnci/51.5.1409 Gooch, 1999, Strain-specific differences in formation of apoptotic DNA ladder in MCF-7 breast cancer cells, Cancer Lett., 144, 31, 10.1016/S0304-3835(99)00208-6 Burrow, 1998, Differences in susceptibility to tumor necrosis factor α-induced apoptosis among MCF-7 breast cancer cell variants, Cancer Res., 58, 4940 Simstein, 2003, Apoptosis, chemoresistance and breast cancer: insights from the MCF-7 cell model system, Exp. Biol. Med., 228, 995, 10.1177/153537020322800903 Lacroix, 2004, Relevance of breast cancer cell lines as models for breast tumors: an update, Breast Cancer Res. Treat., 83, 249, 10.1023/B:BREA.0000014042.54925.cc Scudiero, 1988, Evaluation of a soluble tetrazolium/formazoin assay for cell growth and drug sensitivity in culture using human and other tumor cell lines, Cancer Res., 48, 4827 Lener, 1998, Health effects of environmental exposure to vanadium, 1 Ip, 2000, Induction of apoptosis by conjugated linoleic acid in cultured mammary tumor cells and premalignant lesions of the rat mammary gland, Cancer Epidemiol. Biomarkers Prev., 9, 689 Germain, 1998, Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation, Int. J. Cancer, 75, 578, 10.1002/(SICI)1097-0215(19980209)75:4<578::AID-IJC14>3.0.CO;2-5 Huang, 1999, Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway, Carcinogenesis, 20, 237, 10.1093/carcin/20.2.237 Ye, 1999, Vanadate induces apoptosis in epidermal JB6P+ cells via hydrogen peroxide-mediated reactions, Mol. Cell Biochem., 202, 9, 10.1023/A:1007078915585 Johnstone, 2002, Apoptosis: link between genetics and chemotherapy, Cell, 108, 153, 10.1016/S0092-8674(02)00625-6 Fisher, 1994, Apoptosis in cancer therapy: crossing the threshold, Cell, 78, 539, 10.1016/0092-8674(94)90518-5 Shrivastava, 1991, Can the in vivo maximum tolerated dose be predicted using in vitro techniques? A working hypothesis, ALTA, 19, 393 Shrivastava, 1992, Comparison of in vivo acute lethal potency and in vitro cytotoxicity of 48 chemicals, Cell Biol. Toxicol., 8, 157, 10.1007/BF00260565 Moskalyk, 2003, Processing of vanadium: a review, Miner. Eng., 16, 793, 10.1016/S0892-6875(03)00213-9 French, 1993, Role of vanadium in nutrition: metabolism, and dietary considerations, Life Sci., 52, 339, 10.1016/0024-3205(93)90146-T Rojas, 1999, Are metals dietary carcinogens?, Mutat. Res., 443, 157, 10.1016/S1383-5742(99)00018-6 Minoia, 1994, Trace element values in tissue from inhabitants of the European Community. IV. Influence of Dietary Factors, Sci. Total Environ., 141, 181, 10.1016/0048-9697(94)90027-2 1988 Neilsen, 1990, The essentiality and metabolism of vanadium, 51 Neilsen, 1995, Vanadium in mammalian physiology and nutrition, vol. 31, 543 Diamond, 1963, Vanadiun: excretion, toxicity, lipid effects in man, Am. J. Clin. Nutr., 12, 49 Cohen, 1995, Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin dependent diabetes mellitus, J. Clin. Invest., 95, 2501, 10.1172/JCI117951 Goldfine, 1995, Metabolic Effects of sodium metavanadate in humans with insulin-dependent and non-insulin-dependent diabetes mellitus in vivo and in vitro studies, J. Clin. Endocrinol. Metab., 80, 3311 Somerville, 1962, Effect of vanadium on serum cholesterol, Am. Heart J., 64, 54, 10.1016/0002-8703(62)90091-1 Curran, 1959, Effect of cholesterol synthesis inhibition in normocholesterolemic young men, J. Clin. Invest., 38, 1251, 10.1172/JCI103900 Huang, 2000, Vanadate induces p53 transactivation through hydrogen peroxide and causes apoptosis, J. Biol. Chem., 275, 32516, 10.1074/jbc.M005366200 Narla, 2001, Bis(4,7-dimethyl-1,10 phenanthroline) sulfatooxovanadium(IV) as a novel antileukemic agent with matrix metalloproteinase inhibitory activity, Clin. Cancer Res., 7, 1094 Evangelou, 2002, Vanadium in cancer treatment, Crit. Oncol. Hematol., 42, 249, 10.1016/S1040-8428(01)00221-9 Scrivens, 2003, Cdc25A-inhibitory properties and antineoplastic activity of bis-peroxo-vanadium analogues, Mol. Cancer Ther., 2, 1053